Zeotech (ASX:ZEO) executed a nonbinding memorandum of understanding with i3 Consulting to collaborate on the development, trials, and potential adoption of Zeotech's AusPozz high-reactivity metakaolin in concrete applications, according to a Wednesday Australian bourse filing.
The agreement commenced on Tuesday and will expire 18 months from the date.
i3 Consulting will identify suitable projects, tenders, and opportunities to support the trials of AuzPozz metakaolin products in concrete applications.
The firms completed an initial trial of AusPozz in wind farm applications using a 50% AusPozz mix design.
Its shares rose over 1% in recent trading on Wednesday.